Your browser doesn't support javascript.
loading
FDG-PET to predict long-term outcome from anti-PD-1 therapy in metastatic melanoma.
Dimitriou, F; Lo, S N; Tan, A C; Emmett, L; Kapoor, R; Carlino, M S; Long, G V; Menzies, A M.
Affiliation
  • Dimitriou F; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Lo SN; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • Tan AC; Division of Medical Oncology, National Cancer Centre, Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore.
  • Emmett L; Department of Theranostics and Nuclear medicine, St Vincent's Hospital Sydney, Sydney, Australia.
  • Kapoor R; Mater Hospital, Sydney, Australia.
  • Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney, Australia.
  • Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, Australia; Charles Perkins Centre, The University of Sydney, Sydney,
  • Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Department of Medical Oncology, Royal North Shore and Mater Hospitals, Sydney, Australia. Electronic address: alexander.menzies@sydney.edu.au.
Ann Oncol ; 33(1): 99-106, 2022 01.
Article in En | MEDLINE | ID: mdl-34687894
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fluorodeoxyglucose F18 / Melanoma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: Switzerland
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fluorodeoxyglucose F18 / Melanoma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: Switzerland